Apollo Endosurgery (APEN) to Release Earnings on Monday

Apollo Endosurgery (NASDAQ:APEN) is scheduled to release its earnings data before the market opens on Monday, March 18th. Analysts expect Apollo Endosurgery to post earnings of ($0.31) per share for the quarter.

APEN opened at $3.31 on Friday. Apollo Endosurgery has a one year low of $3.02 and a one year high of $9.65. The company has a market capitalization of $71.14 million, a P/E ratio of -1.65 and a beta of 0.72. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.81 and a current ratio of 2.42.

A number of research firms recently commented on APEN. Zacks Investment Research cut Apollo Endosurgery from a “buy” rating to a “hold” rating in a report on Tuesday, March 5th. Northland Securities upgraded Apollo Endosurgery from an “under perform” rating to a “market perform” rating and set a $3.00 price objective on the stock in a report on Wednesday, January 2nd. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Apollo Endosurgery presently has a consensus rating of “Hold” and a consensus price target of $4.69.

In other Apollo Endosurgery news, major shareholder Stonepine Capital, L.P. sold 250,000 shares of the business’s stock in a transaction that occurred on Thursday, December 27th. The stock was sold at an average price of $3.00, for a total value of $750,000.00. Following the sale, the insider now owns 2,185,426 shares of the company’s stock, valued at $6,556,278. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 52.80% of the company’s stock.

A hedge fund recently raised its stake in Apollo Endosurgery stock. Dimensional Fund Advisors LP raised its position in Apollo Endosurgery Inc (NASDAQ:APEN) by 5.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 123,117 shares of the biotechnology company’s stock after purchasing an additional 6,551 shares during the quarter. Dimensional Fund Advisors LP owned 0.56% of Apollo Endosurgery worth $425,000 as of its most recent SEC filing. 39.30% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Apollo Endosurgery (APEN) to Release Earnings on Monday” was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://www.americanbankingnews.com/2019/03/15/apollo-endosurgery-apen-to-release-earnings-on-monday.html.

About Apollo Endosurgery

Apollo Endosurgery, Inc, a medical technology company, focuses on the design, development, and commercialization of medical devices. It develops and distributes devices for minimally invasive surgical and non-surgical bariatric and gastrointestinal procedures that are used by surgeons and gastroenterologists in various settings to provide interventional therapy to patients who suffer from obesity and various co-morbidities associated with obesity, as well as treat various other gastrointestinal conditions.

Read More: QQQ ETF

Earnings History for Apollo Endosurgery (NASDAQ:APEN)

Receive News & Ratings for Apollo Endosurgery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Endosurgery and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply